| 臺大學術典藏 |
2020-03-06T05:26:31Z |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
|
Wu S.-G.; Gow C.-H.; Yu C.-J.; YIH-LEONG CHANG; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:30Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Wu S.-G.; YIH-LEONG CHANG; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:29Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:27Z |
Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma
|
Ueng T.-H.; YIH-LEONG CHANG; Tsai Y.-Y.; Su J.-L.; Chan P.-K.; Shih J.-Y.; Lee Y.-C.; Ma Y.-C.; Kuo M.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:26Z |
Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers
|
YIH-LEONG CHANG; Wu C.-T.; Shih J.-Y.; Lee Y.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:26Z |
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas
|
YIH-LEONG CHANG; Wu C.-T.; Shih J.-Y.; Lee Y.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:26Z |
Epidermal growth factor receptor mutations in small cell lung cancer: A brief report
|
Shiao T.-H.; YIH-LEONG CHANG; Yu C.-J.; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:25Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; YIH-LEONG CHANG; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:24Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:24Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:23Z |
EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy
|
YIH-LEONG CHANG; Wu C.-T.; Shih J.-Y.; Lee Y.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:23Z |
Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed
|
Chen C.-Y.; YIH-LEONG CHANG; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:22Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:22Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:22Z |
Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment
|
Chung K.-P.; Huang Y.-T.; YIH-LEONG CHANG; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:21Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:20Z |
The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction
|
YIH-LEONG CHANG; Lin M.-W.; Shih J.-Y.; Wu C.-T.; Lee Y.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:19Z |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Wu S.-G.; Hu F.-C.; YIH-LEONG CHANG; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:17Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:16Z |
Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case
|
Gow C.-H.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:16Z |
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ?2 cm in maximal dimension
|
YIH-LEONG CHANG; Yang P.-C.; Lin M.-W.; Wu C.-T.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:13Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:09Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:07Z |
The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition
|
Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; YIH-LEONG CHANG; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:04Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:04Z |
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression
|
Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:03Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:02Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:01Z |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; YIH-LEONG CHANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:00Z |
Primary resistance to osimertinib despite acquired T790M
|
Chang L.-K.; YIH-LEONG CHANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:00Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T03:43:07Z |
Using GHSOM to construct legal maps for Taiwan's securities and futures markets
|
Shih J.-Y.; Chang Y.-J.; Chen W.-H.; WUN-HWA CHEN |
| 臺大學術典藏 |
2020-03-06T03:43:04Z |
Creating virtual collaborative team through the construction of expertise spaces
|
Chen W.-H.;Shih J.-Y.;Hsieh M.-J.; Chen W.-H.; Shih J.-Y.; Hsieh M.-J.; WUN-HWA CHEN |
| 臺大學術典藏 |
2020-03-06T03:43:04Z |
Developing target marketing models for personal loans
|
Shih J.-Y.;Chen W.-H.;Chang Y.-J.; Shih J.-Y.; Chen W.-H.; Chang Y.-J.; WUN-HWA CHEN |
| 臺大學術典藏 |
2020-03-06T03:43:03Z |
A study of Taiwan's issuer credit rating systems using support vector machines
|
Chen W.-H.;Shih J.-Y.; Chen W.-H.; Shih J.-Y.; WUN-HWA CHEN |
| 臺大學術典藏 |
2020-03-05T08:04:11Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.; MIN-SHU HSIEH; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-05T08:04:09Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai T.-H.; Wu S.-G.; MIN-SHU HSIEH; Yu C.-J.; Yang J.C.H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-05T08:04:08Z |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen Y.-F.; MIN-SHU HSIEH; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-05T08:04:03Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Min-Shu Hsieh;Lee M.-R.;Keng L.-T.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; MIN-SHU HSIEH; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-05T08:04:03Z |
Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer
|
Chen C.-Y.;Chen Y.-Y.;Min-Shu Hsieh;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Chen C.-Y.; Chen Y.-Y.; MIN-SHU HSIEH; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-05T08:04:02Z |
Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma
|
Chang L.-C.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.;Min-Shu Hsieh; Chang L.-C.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; MIN-SHU HSIEH |
| 臺大學術典藏 |
2020-03-05T08:04:02Z |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
|
Gow C.-H.;Min-Shu Hsieh;Wu S.-G.;Shih J.-Y.; Gow C.-H.; MIN-SHU HSIEH; Wu S.-G.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-05T08:04:01Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; MIN-SHU HSIEH; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Min-Shu Hsieh;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:57Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Lin Y.-T.; Liu Y.-N.; Shih J.-Y.; MIN-SHU HSIEH; Gow C.-H. |
| 臺大學術典藏 |
2020-03-03T03:36:48Z |
Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women
|
Lu T.-P.;Tsai M.-H.;Lee J.-M.;Hsu C.-P.;Chen P.-C.;Chung-Wu Lin;Shih J.-Y.;Yang P.-C.;Hsiao C.K.;Lai L.-C.;Chuang E.Y.; Lu T.-P.; Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; CHUNG-WU LIN; Shih J.-Y.; Yang P.-C.; Hsiao C.K.; Lai L.-C.; Chuang E.Y. |
| 臺大學術典藏 |
2020-02-27T07:43:25Z |
Cardiac involvement in malignancies: Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma
|
WEN-JONE CHEN;Chiang W.-C.;Chen S.-C.;Chang Y.-L.;Shih J.-Y.;Ko P.C.-I.;Tsai M.-S.; Tsai M.-S.; Ko P.C.-I.; Shih J.-Y.; Chang Y.-L.; Chen S.-C.; Chiang W.-C.; WEN-JONE CHEN |
| 臺大學術典藏 |
2020-02-26T01:37:01Z |
Digital infarcts showing microangiopathy in adult dermatomyositis suggest severe pulmonary involvement and poor prognosis [3]
|
Tjiu, J.-W.; Lin, S.-J.; Wang, L.-F.; Shih, J.-Y.; Yu, C.-J.; Liang, C.-W.; Chu, C.-Y.; SUNG-JAN LIN |
| 臺大學術典藏 |
2020-02-26T01:37:01Z |
Digital infarcts showing microangiopathy in adult dermatomyositis suggest severe pulmonary involvement and poor prognosis [3]
|
Sung-Jan LinTjiu, J.-W.;Lin, S.-J.;Wang, L.-F.;Shih, J.-Y.;Yu, C.-J.;Liang, C.-W.;Chu, C.-Y.; Tjiu, J.-W.; Lin, S.-J.; Wang, L.-F.; Shih, J.-Y.; Yu, C.-J.; Liang, C.-W.; Chu, C.-Y.; SUNG-JAN LIN |
